|
Loading...
Loading...
US Pharm. 2011;36(8):13.
Gaithersburg, MD—The FDA has approved the formulation for the 2011-2012 influenza vaccine. This formulation protects against the three virus strains that surveillance indicates will be most common during the upcoming season. Six manufacturers are licensed to produce and distribute the influenza vaccine in the United States. This includes Fluzone Intradermal (Sanofi Pasteur Inc.), which uses a microinjection needle to deliver the vaccine into the skin instead of the muscle. This recently approved vaccine system will be available for those 18 to 64 years old. The CDC’s Advisory Committee on Immunization Practices recommends that all individuals 6 months of age and older receive an annual influenza vaccination.
To comment on this article, contact rdavidson@uspharmacist.com.
|
Loading...
Loading...
|
|
U.S. Pharmacist is a monthly journal dedicated to providing the nation's pharmacists with up-to-date,
authoritative, peer-reviewed clinical articles relevant to contemporary pharmacy practice in a variety of settings,
including community pharmacy, hospitals, managed care systems, ambulatory care clinics, home care organizations,
long-term care facilities, industry and academia. The publication is also useful to pharmacy technicians, students,
other health professionals and individuals interested in health management. Pharmacists licensed in the U.S. can earn
Continuing Education credits through Postgraduate Healthcare Education, LLC, accredited by the Accreditation Council for Pharmacy Education (ACPE)
as a provider of continuing pharmacy education.
Copyright © 2000 - 2013 Jobson Medical Information LLC unless otherwise noted.
All rights reserved. Reproduction in whole or in part without permission is prohibited.
|